Patents by Inventor Heiko WEYD

Heiko WEYD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Core domain of annexins and uses thereof in antigen delivery and vaccination
    Patent number: 11851463
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: December 26, 2023
    Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Fatmire Bujupi, Peter Krammer, Heiko Weyd
  • Annexin-coated particles
    Publication number: 20220152149
    Abstract: The present invention relates to an annexin-coated particle, comprising a negatively charged phospholipid and an annexin non-covalently coupled thereto. The present invention further relates to a composition comprising an annexin-coated particle. Furthermore, the present invention relates to a product for use in a method of preventing or treating a disease selected from a chronic inflammatory disease, an autoimmune disease, an allergy, and a cancer, said product comprising an annexin-coated particle, and/or a composition. The present invention further relates to a method of preparing an annexin-coated particle.
    Type: Application
    Filed: February 6, 2020
    Publication date: May 19, 2022
    Inventors: Peter KRAMMER, Heiko WEYD, Kevin BODE
  • THE CORE DOMAIN OF ANNEXINS AND USES THEREOF IN ANTIGEN DELIVERY AND VACCINATION
    Publication number: 20210230238
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Application
    Filed: January 21, 2021
    Publication date: July 29, 2021
    Inventors: Fatmire BUJUPI, Peter KRAMMER, Heiko WEYD
  • Core domain of annexins and uses thereof in antigen delivery and vaccination
    Patent number: 10947283
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: March 16, 2021
    Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Fatmire Bujupi, Peter Krammer, Heiko Weyd
  • THE CORE DOMAIN OF ANNEXINS AND USES THEREOF IN ANTIGEN DELIVERY AND VACCINATION
    Publication number: 20190144513
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Application
    Filed: June 8, 2017
    Publication date: May 16, 2019
    Inventors: Fatmire BUJUPI, Peter KRAMMER, Heiko WEYD
  • Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy
    Publication number: 20180275124
    Abstract: The present invention relates to a method for identifying a compound that modulates the interaction of an annexin core domain with a receptor selected from the group of C-type lectin receptors and LRP-1 in a cell, and uses thereof in autoimmune and/or cancer therapy.
    Type: Application
    Filed: November 19, 2015
    Publication date: September 27, 2018
    Applicant: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
    Inventors: Peter H. KRAMMER, Alexandra KURZ, Björn LINKE, Heiko WEYD